Business Context and Reporting Period
Company: Bioaffinity Technologies, Inc. (BIAF)
Filing Type: Form 8-K (Current Report)
Date of Report: September 17, 2025
Reporting Period: Event-specific report regarding corporate actions effective September 18, 2025.
Key Financial Metrics
This filing is a current report regarding a corporate governance action and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Reverse Stock Split: The Board approved a 1-for-30 reverse split of outstanding common stock.
- Effective Date: The split becomes effective at 4:01 p.m. Eastern Time on September 18, 2025.
- Trading Resumption: Common stock will begin trading on a split-adjusted basis on September 19, 2025.
- Security Identifier: The stock will trade under the existing symbol "BIAF" but with a new CUSIP number (09076W307).
- Adjustments: Proportionate adjustments will be made to the exercise price and share counts for all outstanding stock options, restricted stock units, and warrants.
- Fractional Shares: Stockholders entitled to fractional shares will receive cash in lieu thereof.
Guidance, Outlook, and Management Commentary
Purpose of Action: The reverse stock split is primarily intended to bring the Company into compliance with Nasdaq's minimum bid price requirement.
Management Commentary: The filing notes that the split will affect all stockholders uniformly and will not alter any stockholder's percentage ownership interest, except for the treatment of fractional shares. No forward-looking financial guidance or strategic outlook was provided in this specific filing.
Investor Verification Checklist
- Verify the new CUSIP number (09076W307) with your broker to ensure proper trading post-split.
- Confirm the number of shares held post-split (1 share for every 30 pre-split shares).
- Check for cash payments in lieu of fractional shares if the pre-split holding was not a multiple of 30.
- Review the adjusted exercise prices and share quantities for any held options, RSUs, or warrants.
- Monitor the stock price on September 19, 2025, to confirm compliance with Nasdaq listing requirements.